5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors

Page 5 of 5

1. STAAR Surgical Company (NASDAQ:STAA)

PAI’s Stake Value: $193,341,000
Percent of 13F Portfolio: 10.65%
Number of Hedge Fund Holders: 26

STAAR Surgical Company (NASDAQ:STAA) designs, develops, produces, markets, and distributes implanted lenses for the eye. The company was incorporated in 1982 and is placed first on the list of 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors. STAAR Surgical Company (NASDAQ:STAA) has a market capitalization of $6.98 billion and was able to deliver a 158.71% return in the past 12 months.

On July 8, Oppenheimer analyst Steven Lichtman initiated coverage of STAAR Surgical Company (NASDAQ:STAA) with a “Perform” rating and gave his price target of $150.

Palo Alto Investors currently holds 1.27 million shares of STAAR Surgical Company (NASDAQ:STAA) that amount to $193.34 million. The company occupies 10.65% of Palo Alto Investors’ total portfolio.

You can also take a peek at 11 Best Pharma and Biotech Stocks to Buy and 10 Best Biotech Penny Stocks To Buy 

Page 5 of 5